{"title":"Phenylalanine Hydroxylase Deficiency Hospitalizations A Novel Approach to Nutritional Management","authors":"E. Barr, M. Sowa, M. Boyer, R. Chang","doi":"10.1177/1941406415595862","DOIUrl":null,"url":null,"abstract":"Phenylalanine hydroxylase (PAH) deficiency is a metabolic disorder that requires lifelong diet adherence for optimal neurodevelopmental and psychological outcomes. Maintaining phenylalanine (Phe) levels within the desired range (120-360 µmol/L) can be increasingly difficult as children grow older, gain more autonomy, and are affected by social influences. After exhausting outpatient intervention measures with 5 patients with severe PAH deficiency, hospitalization was pursued. Phe levels rapidly decreased in all cases. Despite the inability for 3 of the 5 patients to maintain optimal dietary adherence after hospitalization, the information gained regarding the patients’ protein tolerance was invaluable. Our clinic has found this approach to be a useful tool in the ongoing management of patients with PAH deficiency and will continue to consider hospitalization for our patients who are failing outpatient management.","PeriodicalId":398639,"journal":{"name":"ICAN: Infant, Child, & Adolescent Nutrition","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ICAN: Infant, Child, & Adolescent Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1941406415595862","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Phenylalanine hydroxylase (PAH) deficiency is a metabolic disorder that requires lifelong diet adherence for optimal neurodevelopmental and psychological outcomes. Maintaining phenylalanine (Phe) levels within the desired range (120-360 µmol/L) can be increasingly difficult as children grow older, gain more autonomy, and are affected by social influences. After exhausting outpatient intervention measures with 5 patients with severe PAH deficiency, hospitalization was pursued. Phe levels rapidly decreased in all cases. Despite the inability for 3 of the 5 patients to maintain optimal dietary adherence after hospitalization, the information gained regarding the patients’ protein tolerance was invaluable. Our clinic has found this approach to be a useful tool in the ongoing management of patients with PAH deficiency and will continue to consider hospitalization for our patients who are failing outpatient management.